Frontiers in Pharmacology

Title Publication Date Language Citations
Advances and Challenges of Liposome Assisted Drug Delivery2015/12/011,418
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety2014/01/011,390
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome2017/08/231,094
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning2018/01/23887
Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic2021/04/13775
Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment2019/02/21643
Fibroblasts in fibrosis: novel roles and mediators2014/05/27628
Antioxidant and Oxidative Stress: A Mutual Interplay in Age-Related Diseases2018/10/16578
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?2018/03/22543
NLRP3 inflammasome and its inhibitors: a review2015/11/05537
Glutathione: new roles in redox signaling for an old antioxidant2014/08/26509
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium2018/11/13501
Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization2018/07/17489
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice2020/01/28465
An Overview of Pickering Emulsions: Solid-Particle Materials, Classification, Morphology, and Applications2017/05/23446
Mechanisms and insights into drug resistance in cancer2013/01/01418
Neuroinflammation as a Common Feature of Neurodegenerative Disorders2019/09/12392
Determinants of patient adherence: a review of systematic reviews2013/01/01390
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression2018/01/17376
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis2017/07/14366
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy2017/02/08359
Glutathione and mitochondria2014/07/01351
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer2018/11/22345
Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview2018/08/22343
Carbon-Based Nanomaterials for Biomedical Applications: A Recent Study2019/03/11334
PLGA-Based Nanoparticles in Cancer Treatment2018/11/02333
The Bone Extracellular Matrix in Bone Formation and Regeneration2020/05/26319
Barrier Mechanisms in the Developing Brain2012/01/01311
Phosphodiesterase-4 Inhibitors for the Treatment of Inflammatory Diseases2018/10/17311
Heme Oxygenase-1, Oxidation, Inflammation, and Atherosclerosis2012/01/01309